tradingkey.logo
搜索

GeneDx Holdings Corp

WGS
添加自选
65.110USD
-3.850-5.58%
收盘 07-31 16:00美东报价延迟15分钟
1.93B总市值
亏损市盈率 TTM

关于 GeneDx Holdings Corp 公司

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp简介

公司代码WGS
公司名称GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOStueland (Katherine A)
员工数量1000
证券类型Ordinary Share
年结日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编06902
电话18887291206
网址https://sema4.com/
公司代码WGS
上市日期Sep 04, 2020
CEOStueland (Katherine A)

GeneDx Holdings Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
189.57K
+1.89%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
29.90K
+11.96%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
23.70K
+15.09%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
189.57K
+1.89%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
29.90K
+11.96%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
23.70K
+15.09%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

常见问题

GeneDx Holdings Corp的前五大股东是谁?

GeneDx Holdings Corp 的前五大股东如下:Mr. Joshua Ruch

哪个业务部门对GeneDx Holdings Corp的收入贡献最大?

在2026Q4,Patients with third party insurance业务部门对GeneDx Holdings Corp的收入贡献最大,创收345.24M,占总收入的80.75%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有